Advisor Group Holdings, Inc. Nektar Therapeutics Transaction History

Advisor Group Holdings, Inc.

  • $44.4 Billion
  • Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Nektar Therapeutics stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 18,567 shares of NKTR stock, worth $438,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,567
Previous 81,322 77.17%
Holding current value
$438,181
Previous $55,000 770.91%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$0.49 - $29.68 $30,749 - $1.86 Million
-62,755 Reduced 77.17%
18,567 $479,000
Q1 2025

May 12, 2025
BUY
$0.66 - $1.19 $26,040 - $46,951
39,455 Added 94.24%
81,322 $55,000
Q4 2024

Jun 06, 2025
SELL
$0.9 - $1.45 $36,229 - $58,369
-40,255 Reduced 49.5%
41,067 $38,000
Q4 2024

Feb 07, 2025
SELL
$0.9 - $1.45 $180 - $290
-200 Reduced 0.48%
41,867 $38,000
Q3 2024

Nov 13, 2024
BUY
$1.11 - $1.48 $3,704 - $4,938
3,337 Added 8.62%
42,067 $54,000
Q2 2024

Aug 13, 2024
SELL
$0.9 - $1.83 $7,920 - $16,105
-8,801 Reduced 18.52%
38,730 $48,000
Q1 2024

May 10, 2024
BUY
$0.49 - $0.96 $6,737 - $13,200
13,750 Added 40.7%
47,531 $44,000
Q4 2023

Feb 12, 2024
SELL
$0.42 - $0.57 $4,477 - $6,076
-10,660 Reduced 23.99%
33,781 $18,000
Q3 2023

Nov 13, 2023
SELL
$0.51 - $1.05 $1,543 - $3,177
-3,026 Reduced 6.37%
44,441 $26,000
Q2 2023

Aug 10, 2023
BUY
$0.53 - $1.03 $2,118 - $4,116
3,997 Added 9.19%
47,467 $27,000
Q1 2023

May 12, 2023
BUY
$0.64 - $3.15 $1,368 - $6,734
2,138 Added 5.17%
43,470 $30,000
Q4 2022

Feb 10, 2023
SELL
$2.03 - $4.28 $8,992 - $18,960
-4,430 Reduced 9.68%
41,332 $93,000
Q3 2022

Nov 14, 2022
BUY
$3.04 - $5.14 $583 - $986
192 Added 0.42%
45,762 $147,000
Q2 2022

Aug 10, 2022
SELL
$3.17 - $6.17 $2,795 - $5,441
-882 Reduced 1.9%
45,570 $174,000
Q1 2022

May 04, 2022
BUY
$4.16 - $13.72 $78,054 - $257,428
18,763 Added 67.76%
46,452 $3.46 Million
Q3 2021

Nov 05, 2021
SELL
$13.07 - $18.84 $173,425 - $249,987
-13,269 Reduced 32.4%
27,689 $498,000
Q2 2021

Aug 02, 2021
BUY
$16.52 - $20.4 $113,938 - $140,698
6,897 Added 20.25%
40,958 $702,000
Q1 2021

May 13, 2021
SELL
$16.56 - $25.46 $31,232 - $48,017
-1,886 Reduced 5.25%
34,061 $681,000
Q4 2020

Feb 10, 2021
SELL
$15.77 - $19.03 $43,714 - $52,751
-2,772 Reduced 7.16%
35,947 $611,000
Q3 2020

Nov 12, 2020
BUY
$16.59 - $24.79 $67,106 - $100,275
4,045 Added 11.67%
38,719 $645,000
Q2 2020

Aug 14, 2020
SELL
$16.86 - $23.44 $194,244 - $270,052
-11,521 Reduced 24.94%
34,674 $803,000
Q1 2020

May 18, 2020
BUY
$14.47 - $27.96 $668,441 - $1.29 Million
46,195 New
46,195 $809,000

Others Institutions Holding NKTR

# of Institutions
26
Shares Held
16.8M
Call Options Held
17.2K
Put Options Held
0
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $4.42B
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email